Omega Healthcare Investors (NYSE:OHI) Updates FY 2024 Earnings Guidance

Omega Healthcare Investors (NYSE:OHI) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided earnings per share guidance of 2.700-2.800 for the period, compared to the consensus earnings per share estimate of 2.730. The company issued revenue guidance of -.

Omega Healthcare Investors Stock Down 0.7 %

OHI stock traded down $0.22 during midday trading on Monday, reaching $31.12. 803,785 shares of the company’s stock traded hands, compared to its average volume of 1,739,825. Omega Healthcare Investors has a 52 week low of $27.53 and a 52 week high of $34.77. The firm’s fifty day moving average price is $30.98 and its 200-day moving average price is $30.97. The company has a quick ratio of 6.76, a current ratio of 6.68 and a debt-to-equity ratio of 1.36. The company has a market cap of $7.68 billion, a price-to-earnings ratio of 28.07, a P/E/G ratio of 10.26 and a beta of 0.92.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Tuesday, April 30th will be issued a dividend of $0.67 per share. The ex-dividend date of this dividend is Monday, April 29th. This represents a $2.68 dividend on an annualized basis and a yield of 8.61%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 241.44%.

Analyst Ratings Changes

A number of equities research analysts have recently commented on OHI shares. JMP Securities reiterated a market perform rating on shares of Omega Healthcare Investors in a research note on Monday. Citigroup raised shares of Omega Healthcare Investors from a neutral rating to a buy rating and increased their target price for the company from $32.00 to $35.00 in a research report on Friday, March 22nd. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Omega Healthcare Investors in a report on Tuesday, January 30th. They issued a buy rating and a $36.00 price target on the stock. Truist Financial increased their price objective on Omega Healthcare Investors from $31.00 to $32.00 and gave the company a hold rating in a report on Tuesday, April 2nd. Finally, Bank of America cut Omega Healthcare Investors from a buy rating to a neutral rating and dropped their price target for the company from $33.00 to $31.00 in a research report on Tuesday, January 16th. Eight investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, Omega Healthcare Investors has an average rating of Hold and an average target price of $33.63.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.